Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 23:11:149-157.
doi: 10.2147/DMSO.S163062. eCollection 2018.

Plasma concentrations of zonulin are elevated in obese men with fatty liver disease

Affiliations

Plasma concentrations of zonulin are elevated in obese men with fatty liver disease

A-Sol Kim et al. Diabetes Metab Syndr Obes. .

Abstract

Purpose: Zonulin is considered as a biomarker of increased intestinal permeability. The relationship between intestinal permeability and obesity is known, and many studies have investigated the relationship between intestinal permeability and liver disease. Thus, we aimed to investigate the potential association between plasma zonulin concentrations and fatty liver in obese men.

Patients and methods: A total of 140 obese men without inflammatory bowel diseases, autoimmune diseases, and severe liver diseases were included. The subjects were divided into three groups: normal, mild fatty liver, and moderate-to-severe fatty liver, according to abdominal ultrasonography findings. We subdivided the subjects into two subgroups based on the amount of alcohol consumption (appropriate drinking and hazardous drinking), and subgroup analyses were performed.

Results: The mean plasma zonulin concentrations (ng/mL) in the normal, mild fatty liver, and moderate-to-severe fatty liver groups were 0.618, 2.143, and 5.815, respectively (P<0.001). A multivariate multinomial logistic regression analysis revealed an odds ratio (OR) of 1.77 (P=0.015) in the moderate-to-severe fatty liver group. The median plasma zonulin concentrations (ng/mL) in the appropriate drinking subgroup of the fatty liver groups were 0.002, 0.500, and 6.550, respectively (P-trend<0.001), and in the hazardous drinking subgroup were 0.002, 0.590, and 5.800, respectively (P-trend=0.001). The ORs for moderate-to-severe fatty liver were 1.91 (P=0.039) in the appropriate drinking group and 1.56 (P=0.045) in the hazardous drinking group.

Conclusion: Plasma zonulin concentrations were elevated among obese men. A significant association was found between zonulin concentrations and severity of fatty liver.

Keywords: fatty liver; intestinal permeability; obesity; zonulin.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
OR of zonulin concentration in fatty liver disease in the appropriate drinking subgroup. Notes: In the multivariate multinomial logistic regression analysis adjusted for covariates, the OR of zonulin concentrations in relation to the incidence of mild fatty liver was 1.63 (adjusted OR=1.63, 95% CI=0.75–3.55) in the appropriate drinking group and was not statistically significant. However, the OR for moderate-to-severe fatty liver was 1.91 (95% CI=1.01–3.95) in the same group and was statistically significant. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 2
Figure 2
OR of zonulin concentration in fatty liver disease in the hazardous drinking subgroup. Notes: In the multivariate multinomial logistic regression analysis adjusted for covariates, the OR of zonulin concentrations in relation to the incidence of mild fatty liver was 1.17 (95% CI=0.69–1.96) in the hazardous drinking group and was not statistically significant. However, the OR for moderate-to-severe fatty liver was 1.56 (95% CI=1.02–2.67) in the same group and was statistically significant. Abbreviation: OR, odds ratio.

References

    1. Madara JL, Moore R, Carlson S. Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction. Am J Physiol. 1987;253(6):C854–C861. - PubMed
    1. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34(4):385–396. - PubMed
    1. Van Elburg R, Uil J, Mulder C, Heymans H. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut. 1993;34(3):354–357. - PMC - PubMed
    1. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2001;48(2):206–211. - PMC - PubMed
    1. Sapone A, de Magistris L, Pietzak M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55(5):1443–1449. - PubMed

LinkOut - more resources